CG vs IVZ
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 12, 2026
CG
40.1
AI Score
VS
IVZ Wins
IVZ
63.5
AI Score
Investment Advisor Scores
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | CG | IVZ | Winner |
|---|---|---|---|
| Revenue | 1.71B | 5.44B | IVZ |
| Net Income | -2.80M | 913.60M | IVZ |
| Net Margin | -0.2% | 16.8% | IVZ |
| ROE | -0.0% | 7.2% | IVZ |
| ROA | -0.0% | 3.3% | IVZ |
| Total Assets | 28.18B | 27.65B | CG |
| Cash | 1.58B | 965.50M | CG |
| Free Cash Flow | -969.30M | 1.34B | IVZ |
Relative Price Performance (Last 90 Days)
CG 1M: +10.4%
· 3M: -20.0%
IVZ 1M: -1.0%
· 3M: -11.5%
Current Technical Phase
CG
NeutralHold
Mixed signals - no dominant trend phase, RSI 54
IVZ
NeutralHold
Mixed signals - no dominant trend phase, RSI 49
Fundamentals Snapshot
| Metric | CG | IVZ |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 8.5 | 8.7 |
| Trailing P/E | 43.9 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.2% | 0.1% |
| Gross Margin | 1.0% | 0.3% |
| Operating Margin | -0.5% | 0.2% |
| EPS | 0.95 | -0.69 |
| Dividend Yield | 0.03% | 0.03% |
Frequently Asked Questions
Based on our detailed analysis, IVZ is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.